Welcome to LookChem.com Sign In|Join Free

CAS

  • or

129095-62-1

Post Buying Request

129095-62-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

129095-62-1 Usage

Description

TERT-BUTYL [(1R)-2-AMINO-1-BENZYL-2-OXOETHYL]CARBAMATE is a complex carbamate compound characterized by the presence of a tert-butyl group, a carbamate functional group, a benzyl group, an amino group, and an oxoethyl group. Its intricate molecular structure suggests potential applications in the pharmaceutical industry, possibly as a drug candidate or a precursor for the synthesis of other bioactive compounds. Further research is essential to explore its specific properties and potential uses.

Uses

Used in Pharmaceutical Industry:
TERT-BUTYL [(1R)-2-AMINO-1-BENZYL-2-OXOETHYL]CARBAMATE is used as a potential drug candidate for its unique molecular structure, which may offer novel therapeutic properties and applications in medicine.
Used in Synthesis of Bioactive Compounds:
In the pharmaceutical industry, TERT-BUTYL [(1R)-2-AMINO-1-BENZYL-2-OXOETHYL]CARBAMATE is used as a precursor in the synthesis of other bioactive compounds, leveraging its complex structure to create new molecules with potential medicinal value.
Further research is needed to fully understand the specific applications and benefits of TERT-BUTYL [(1R)-2-AMINO-1-BENZYL-2-OXOETHYL]CARBAMATE in various fields, particularly in the development of new pharmaceuticals and therapeutic agents.

Check Digit Verification of cas no

The CAS Registry Mumber 129095-62-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,9,0,9 and 5 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 129095-62:
(8*1)+(7*2)+(6*9)+(5*0)+(4*9)+(3*5)+(2*6)+(1*2)=141
141 % 10 = 1
So 129095-62-1 is a valid CAS Registry Number.

129095-62-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name tert-butyl N-[(2R)-1-amino-1-oxo-3-phenylpropan-2-yl]carbamate

1.2 Other means of identification

Product number -
Other names NH2-D-Phe-NHBoc

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:129095-62-1 SDS

129095-62-1Relevant articles and documents

Synthesis, anti-inflammatory and antimicrobial activities of new 1,2,4-oxadiazoles peptidomimetics

Leite, Ana Cristina L.,Vieira, Renata F.,De Faria, Antonio R.,Wanderley, Almir G.,Afiatpour, Parviz,Ximenes, Eulalia Camelo P. A.,Srivastava, Rajendra M.,De Oliveira, Claudia F.,Medeiros,Antunes, Edson,Brondani, Dalci J.

, p. 719 - 724 (2000)

A new series of 1,2,4-oxadizoles 6a-g have been synthesised in good yields using the peptide synthesis strategy. The prepared compounds were tested for anti-inflammatory and antimicrobial activities. The anti-inflammatory activities were determined in the

Mapping the s1 and s1’ subsites of cysteine proteases with new dipeptidyl nitrile inhibitors as trypanocidal agents

Cianni, Lorenzo,Lemke, Carina,Gilberg, Erik,Feldmann, Christian,Rosini, Fabiana,Rocho, Fernanda Dos Reis,Ribeiro, Jean F. R.,Tezuka, Daiane Y.,Lopes, Carla D.,de Albuquerque, Sérgio,Bajorath, Jürgen,Laufer, Stefan,Leit?o, Andrei,Gütschow, Michael,Montanariid, Carlos A.

, (2020/04/24)

The cysteine protease cruzipain is considered to be a validated target for therapeutic intervention in the treatment of Chagas disease. A series of 26 new compounds were designed, synthesized, and tested against the recombinant cruzain (Cz) to map its S1/S1′ subsites. The same series was evaluated on a panel of four human cysteine proteases (CatB, CatK, CatL, CatS) and Leishmania mexicana CPB, which is a potential target for the treatment of cutaneous leishmaniasis. The synthesized compounds are dipeptidyl nitriles designed based on the most promising combinations of different moieties in P1 (ten), P2 (six), and P3 (four different building blocks). Eight compounds exhibited a Ki smaller than 20.0 nM for Cz, whereas three compounds met these criteria for LmCPB. Three inhibitors had an EC50 value of ca. 4.0 μM, thus being equipotent to benznidazole according to the antitrypanosomal effects. Our mapping approach and the respective structure-activity relationships provide insights into the specific ligand-target interactions for therapeutically relevant cysteine proteases.

Synthesis and structure-activity relationship of nitrile-based cruzain inhibitors incorporating a trifluoroethylamine-based P2 amide replacement

Gomes, Juliana C.,Cianni, Lorenzo,Ribeiro, Jean,dos Reis Rocho, Fernanda,da Costa Martins Silva, Samelyn,Batista, Pedro Henrique Jatai,Moraes, Carolina Borsoi,Franco, Caio Haddad,Freitas-Junior, Lucio H.G.,Kenny, Peter W.,Leit?o, Andrei,Burtoloso, Antonio C.B.,de Vita, Daniela,Montanari, Carlos A.

, (2019/09/30)

The structure-activity relationship for nitrile-based cruzain inhibitors incorporating a P2 amide replacement based on trifluoroethylamine was explored by deconstruction of a published series of inhibitors. It was demonstrated that the P3 biphenyl substituent present in the published inhibitor structures could be truncated to phenyl with only a small loss of affinity. The effects of inverting the configuration of the P2 amide replacement and linking a benzyl substituent at P1 were observed to be strongly nonadditive. We show that plotting affinity against molecular size provides a means to visualize both the molecular size efficiency of structural transformations and the nonadditivity in the structure-activity relationship. We also show how the relationship between affinity and lipophilicity, measured by high-performance liquid chromatography with an immobilized artificial membrane stationary phase, may be used to normalize affinity with respect to lipophilicity.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 129095-62-1